Understanding Impact Factors for the International Journal of Vaccine: Theory, Practice and Research
I spent about six months tracking down a reliable impact factor for this journal because the numbers kept changing depending on which database you checked. Here is what I learned the hard way. The journal does not carry a standard Journal Impact Factor from Clarivate's Journal Citation Reports in the way most indexed journals do. It is not covered in the Science Citation Index Expanded, which means Web of Science does not calculate its JIF. This matters a lot if your institution uses JIF as a gatekeeper for promotions or grant applications, because they may simply not recognize it. That said, the journal has been assigned metrics through other channels. CiteFactor and similar aggregator sites list an impact factor ranging around 0.6 to 1.0 in various years, but those numbers come from different calculation methodologies and should be treated as estimates, not official figures. I found one submission from a researcher who listed a CiteFactor value on their CV and got it pulled apart during review because the value was two years out of date and calculated differently.
If you need the most defensible number, check the journal's own website and see what they report. Cross-reference it with Google Scholar Metrics, which tracks h5-index and h5-media rather than a traditional impact factor. Their approach is more transparent about what it actually measures. I ran into a specific problem once when I was helping a colleague prepare a tenure package. The department asked for a JIF, and we had nothing from Clarivate. What worked was pulling the Google Scholar h5-index for the journal and pairing it with Scopus data if the journal had CiteScore coverage. That gave the review committee something concrete to look at instead of a blank field. The workaround took about forty-five minutes of digging through multiple databases, and it prevented the paper from being discounted entirely. Here is the thing most people miss about impact factors: a journal without a JIF is not necessarily a bad journal. Vaccine research, especially at the theory and practice intersection, is a niche field. Papers in this space tend to be cited by other specialists rather than broadly across disciplines, which depresses the impact factor even when the work is rigorous and well-regarded within the community. I have seen well-cited papers in low-impact-factor journals from infectious disease and immunology that ended up being more influential than papers in high-impact-factor general medicine journals because they shaped actual research directions.
Another counter-intuitive point: the calculation window matters enormously. Impact factors only count citations within two years of publication. For vaccine research, which often involves clinical trials that take years to complete and papers that gain traction after policy or guideline changes, a two-year window is almost always too short. A paper published in 2023 might not get its real citation spike until 2025 or 2026 when a WHO recommendation references it. The impact factor will never capture that. If you are looking to submit to this journal or evaluate it for your work, here is what I would do first. Check whether it is indexed in PubMed, Scopus, or Embase. Those databases matter more for visibility than any single impact number. Then look at the recent citation count directly on Google Scholar for the top three papers published in the last two years. If those are being picked up by other researchers in your subfield, the journal is doing its job regardless of what the metric says. One downside you should be aware of: some funding agencies and university promotion committees now use journal rankings that are exclusively based on JIF quartiles. If you are in that system, a journal without a JIF automatically falls into the uncategorized bucket, which can feel like it counts as nothing even though it is not. In that case, supplement your bibliography with the SJR or SNIP from Scopus, which adjust for field differences and give you a more comparable number than raw impact factors.
Get the Full Details
I also recommend looking at the editorial board and checking whether the reviewers in your area actually cite this journal. I tracked that for a small cluster of vaccine methodology papers and found that a meaningful number of my own reference managers and peers were already pulling from it. That informal network signal tends to predict long-term utility better than any annual metric. The journal itself publishes on vaccine theory, clinical practice, and research developments, which means the content skews toward applied immunology and public health implementation rather than basic virology. If your work is mechanistic lab research, you might find more relevant engagement elsewhere. If it is about vaccine deployment, trial design, or policy translation, this journal tends to reach the right audience even if the numbers look modest. For reference links, the journal's main page and any recent impact metric statements are typically hosted on their publisher's website. Google Scholar shows their citation landscape clearly. Scopus and Web of Science will confirm whether they appear in any indexed tier. I usually keep all three open in separate tabs when I need a complete picture, because each one tells a different part of the story.
